Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Arena Pharmaceuticals, Inc.    ARNA   US0400471027

Delayed Quote. Delayed Nasdaq - 01/23 04:00:00 pm
4.55 USD   -2.36%
01/21 ARENA PHARMACEU : Announces Agreement to Sell Common Stock
01/20 ARENA PHARMACEU : Announces Public Offering of Common Stock
01/13 APPLE : Most active Nasdaq-traded stocks
SummaryQuotesChart AnalysisNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
 News SummaryMost relevantAll newsSector news 
Most relevant news about ARENA PHARMACEUTICALS, INC
01/21 ARENA PHARMACEUTICALS : Announces Agreement to Sell Common Stock
01/20 ARENA PHARMACEUTICALS : Announces Public Offering of Common Stock
01/13 APPLE : Most active Nasdaq-traded stocks
01/12 ARENA PHARMACEUTICALS : Initiates Phase 2 Clinical Trial Evaluating Ralinepag fo..
01/09 ARENA PHARMACEUTICALS : Reports on Eisai's New Marketing Initiatives for BELVIQ®..
01/08 APPLE : Most active Nasdaq-traded stocks
01/08 Biotechs see heavy action after drug study results
01/07 ARENA PHARMACEUTICALS : Nasdaq stocks posting largest percentage increases
01/07 ARENA PHARMACEUTICALS : Pharma surges on data from autoimmune drug study
01/07 ARENA PHARMACEUTICALS : Reports Positive Results from Phase 1b Clinical Trial Ev..
01/06 ARENA PHARMACEUTICALS : to Present at the 33rd Annual J.P. Morgan Healthcare Con..
2014 ARENA PHARMACEUTICALS : Issued Composition of Matter Patent by United States Pat..
2014 ARENA PHARMACEUTICALS : to Present at Piper Jaffray 26th Annual Healthcare Confe..
2014 ARENA PHARMACEUTICALS : to Present at Stifel 2014 Healthcare Conference
2014 ARENA PHARMACEUTICALS : Lorcaserin HCl Data to be Presented at the Annual Meetin..
More most relevant news
All news about ARENA PHARMACEUTICALS, INC
01/23 ARENA PHARMACEUTICALS : Initiates Phase 2 Clinical Trial Evaluating Ralinepag fo..
01/21 ARENA PHARMACEUTICALS : Announces Agreement to Sell Common Stock
01/20 ARENA PHARMACEUTICALS : Results of Operations and Financial Condition, Other Eve..
01/20 ARENA PHARMACEUTICALS : Announces Public Offering of Common Stock
01/14 ARENA PHARMACEUTICALS : Reports on Eisai's New Marketing Initiatives for BELVIQ®..
01/14 ARENA PHARMACEUTICALS : Reports Positive Results from Phase 1b Clinical Trial Ev..
01/14 ARENA PHARMACEUTICALS : to Present at the 33rd Annual J.P. Morgan Healthcare Con..
01/13 APPLE : Most active Nasdaq-traded stocks
01/12 ARENA PHARMACEUTICALS : Initiates Phase 2 Clinical Trial Evaluating Ralinepag fo..
01/09 ARENA PHARMACEUTICALS : Reports on Eisai's New Marketing Initiatives for BELVIQ®..
More news
Sector news Biotechnology & Medical Research - NEC
01/23 INCYTE : Earns $25 Million Milestone as Jakavi® (ruxolitinib) Recommended for Ap..
01/23 MEDIVATION : Astellas -enzalutamide phase 2 terrain trial demonstrated statistic..
01/22 QUINTILES TRANSNATIONAL : Investigator Initiated Trials is Topic of New Handbook..
01/22 PUMA BIOTECHNOLOGY : Announces Underwriters’ Full Exercise of Option to Pu..
01/22 MEDIVATION : Enzalutamide Phase 2 Terrain Trial Demonstrated Statistically Signi..
01/21 PUMA BIOTECHNOLOGY : Prices Public Offering of Common Stock
Plus d'actualités du secteur Biotechnology & Medical Research - NEC


Advertisement
Chart
Duration : Period :
Arena Pharmaceuticals, Inc Technical Analysis Chart | ARNA | US0400471027 | 4-Traders
Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF